Objectives Recent reports suggest that florbetapir F18 (AV-45) is a new PET imaging agent targeting Aβ aggregates in the brain of patient with Alzheimer’s disease. Similarly, accumulation of Aβ ...

Following the Food and Drug Administration’s approval of Lutathera and Pluvicto in 2018 and 2022, respectively, we predicted ...

Cancer therapy has advanced with molecularly targeted approaches and immunotherapy, yet chemotherapy remains essential for ...

Pattern of Failure in Patients with Biochemical Recurrence After PSMA Radioguided Surgery Perspective on Pattern of Failure in Patients with Biochemical Recurrence After PSMA Radioguided Surgery ...

SPECT Deserves RESPECT: The Potential of SPECT/CT to Optimize Patient Outcomes with Theranostics Therapy ...

The Influence of Specific Activity on the Biodistribution of 18F-rhPSMA-7.3: A Retrospective Analysis of Clinical PET Data Prostate-specific membrane antigen positron emission tomography compared to ...

The Chinese Society of Nuclear Medicine conducted a national nuclear medicine survey in January 2024. The purpose of the survey was to update the data from 2019 and provide a scientific basis for ...

Journal of Nuclear Medicine February 2025, jnumed.124.268496; DOI: https://doi.org/10.2967/jnumed.124.268496 This paper aims to develop and evaluate the potential of ...

Journal of Nuclear Medicine February 2025, jnumed.124.268835; DOI: https://doi.org/10.2967/jnumed.124.268835 ...

Journal of Nuclear Medicine February 2025, jnumed.124.268818; DOI: https://doi.org/10.2967/jnumed.124.268818 ...

Objectives Various iodine isotopes in the form of iodide are important radiopharmaceuticals in nuclear medicine. The current biokinetic models for iodide, intended for use in connection with ...